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Summary
Homeostatic plasticity may compensate for Hebbian
forms of synaptic plasticity, such as long-term poten-
tiation (LTP) and depression (LTD), by scaling neuro-
nal output without changing the relative strength of
individual synapses. This delicate balance between
neuronal output and distributed synaptic weight may
be necessary for maintaining efficient encoding of in-
formation across neuronal networks. Here, we demon-
strate that Arc/Arg3.1, an immediate-early gene (IEG)
that is rapidly induced by neuronal activity associated
with information encoding in the brain, mediates
homeostatic synaptic scaling of AMPA type glutamate
receptors (AMPARs) via its ability to activate a novel
and selective AMPAR endocytic pathway. High levels
of Arc/Arg3.1 block the homeostatic increases in
AMPAR function induced by chronic neuronal inactiv-
ity. Conversely, loss of Arc/Arg3.1 results in increased
AMPAR function and abolishes homeostatic scaling
of AMPARs. These observations, together with evi-
dence that Arc/Arg3.1 is required for memory
consolidation, reveal the importance of Arc/Arg3.1’s
dynamic expression as it exerts continuous and
precise control over synaptic strength and cellular
excitability.
Introduction
Arc/Arg3.1 is an immediate-early gene (IEG) that is dy-
namically regulated by neuronal activity and is tightly
coupled to behavioral encoding of information in neuro-
nal circuits (Guzowski et al., 2005). Arc/Arg3.1 mRNA
traffics to distal dendrites where it accumulates at sites
of synaptic activity and is locally translated (Steward
et al., 1998). In vivo, Arc/Arg3.1 is coordinately induced
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search, 2500 Valby, Denmark.in populations of neurons that mediate learning, such
as place cells of the hippocampus (Ramirez-Amaya
et al., 2005) and behavior-specific neural networks in pa-
rietal (Burke et al., 2005), visual (Tagawa et al., 2005;
Wang et al., 2006), and olfactory (Zou and Buck, 2006)
cortices. For example, 5 min of spatial exploration elicits
transcriptional induction of Arc/Arg3.1 inw40% of CA1
neurons (Guzowski et al., 2005). Moreover, Arc/Arg3.1 is
repeatedly induced in the same network during explora-
tion of the same space (Guzowski et al., 2006) and during
memory consolidation (Ramirez-Amaya et al., 2005), in-
dicating that in vivo expression can be maintained at el-
evated steady-state levels in specific neuronal net-
works. Consistent with the notion that Arc/Arg3.1
protein is required for learning and memory (Guzowski
et al., 2000), Arc/Arg3.1 knockout (KO) mice demon-
strate impaired maintenance of LTP and consolidation
of long-term memory but exhibit normal short-term
memory (Plath et al., 2006 [this issue ofNeuron]). Molec-
ular studies indicate that Arc/Arg3.1 modulates AMPAR
trafficking by interacting with two proteins intricately in-
volved in endocytosis, endophilin 2/3 and dynamin
(Chowdhury et al., 2006 [this issue of Neuron]).
Changes in synaptic strength are proposed to under-
lie memory storage in neuronal circuits (Malenka and
Nicoll, 1999; Martin et al., 2000). Hebbian forms of plas-
ticity such as LTP and LTD can modify the strength of
individual synapses. However, unrestrained potentia-
tion or depression can result in saturation of a neuron’s
ability to encode information (Moser et al., 1998). Ho-
meostatic compensation for these acute changes in
synaptic strength is required to maintain neuronal out-
put in the normal range but must be accomplished
without erasing information encoded by the distributed
synaptic strengths (Davis and Bezprozvanny, 2001;
Turrigiano and Nelson, 2004). For example, chronic
blockade of network activity for several days results
in an increase in surface and synaptic AMPARs,
while a chronic increase in activity reduces surface
and synaptic AMPARs (O’Brien et al., 1998; Turrigiano
et al., 1998).
Here, we present evidence that the Arc/Arg3.1-
endocytic pathway mediates homeostatic scaling of
AMPARs. Arc/Arg3.1 protein is dynamically regulated
by chronic changes in neuronal activity that normally
evokes synaptic scaling. Overexpression of Arc/Arg3.1
blocks the upregulation of surface AMPARs and
mEPSCs induced by chronic neuronal inactivity. Con-
versely, Arc/Arg3.1 KO neurons exhibit a scaled in-
crease in surface AMPARs and AMPAR-mediated
mEPSCs that mimics the upregulation of synaptic func-
tion induced by chronic inactivity. Strikingly, Arc/Arg3.1
KO neurons exhibit gross deficits in homeostatic scaling
of surface AMPARs and AMPAR-mediated mEPSCs.
These findings support a simple model in which Arc/
Arg3.1 regulates an endocytic pathway whose activity
is continuously coupled to neuronal excitability by the
transcription of Arc/Arg3.1. This process regulates
steady-state AMPARs and permits the homeostatic
scaling of synaptic strength.
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476Figure 1. Arc/Arg3.1 Protein Is Dynamically Regulated by Neuronal Activity in Primary Culture
(A) Endogenous Arc/Arg3.1 is expressed in the cell body and dendrites of DIV 28 primary hippocampal neurons. There is enrichment of protein at
synapses, as shown by colocalization with the presynaptic marker bassoon. (Scale bars represent 30 mm and 8 mm in magnified dendrites.)
(B) Representative pictures of Arc/Arg3.1 protein in DIV 28 primary cortical neurons. Arc/Arg3.1 protein is downregulated after 2 days of TTX
treatment and is conversely upregulated with 2 days of bicuculline treatment. (Pictures are shown using a Glow scale, with white as the highest
pixel intensity and red as the lowest intensity. Scale bar, 80 mm.)
(C) Quantification of protein levels in cortical neurons shows a significant downregulation with TTX treatment (n = 41 cells) as compared with
untreated neurons (n = 38) and a significant upregulation with bicculline treatment (n = 48). (*p < 0.05). Error bars in all figures represent the stan-
dard error of the mean.Results
Arc/Arg3.1 Protein Expression Is Regulated by
Neuronal Activity in Primary Culture
Arc/Arg3.1 mRNA induction and protein synthesis are
regulated by neuronal activity in vivo (Steward et al.,
1998; Steward and Worley, 2001). To elucidate the syn-
aptic function of Arc/Arg3.1, we examined Arc/Arg3.1
expression in primary neuronal cultures. Many features
of Arc/Arg3.1 that are observed in vivo are also recapit-
ulated in culture (Rao et al., 2006). Arc/Arg3.1 expres-
sion is relatively low in preadolescent brain but reaches
peak levels by postnatal day 28 (Lyford et al., 1995).
Similarly, in primary hippocampal or cortical cultures,
Arc/Arg3.1 expression is relatively low prior to 12 days
in vitro (DIV) but increases markedly in older neurons
(data not shown) and correlates with the appearance
of mature synapses. In these older cultures, Arc/Arg3.1
protein is present throughout distal dendrites and
spines, and many of these puncta colocalize with the
synaptic marker bassoon (Figure 1A). Arc/Arg3.1 ex-
pression in primary culture is also dependent on sponta-
neous neuronal activity, which is consistent with its role
as an IEG (Figures 1B and 1C). Long-term TTX treatment
of high-density cortical neurons, which blocks all
evoked neuronal activity, significantly reduces Arc/
Arg3.1 expression. Bicuculline, which blocks inhibitory
neurotransmission mediated by GABAA receptors and
increases neuronal firing, significantly increases Arc/Arg3.1 expression (Figures 1B and 1C). Similar results
are seen in low-density hippocampal neurons (data not
shown).
Arc/Arg3.1 Blocks Homeostatic Scaling of AMPARs
Induced by Chronic Blockade of Neuronal Activity
Since Arc/Arg3.1 expression is reciprocally regulated by
activity and facilitates AMPAR endocytosis (Chowdhury
et al., 2006), we hypothesized that Arc/Arg3.1 may be in-
volved in mechanisms that permit homeostatic AMPAR
scaling. Consistent with this idea, overexpression of
Arc/Arg3.1 results in a cell-wide decrease in the surface
expression of GluR1-containing AMPARs, mimicking the
effect observed with chronic bicuculline treatment (Fig-
ures 2A and 2B). Arc/Arg3.1 overexpression also
blocked the homeostatic upregulation of GluR1 induced
by chronic TTX treatment (Figures 2A and 2B). This indi-
cates that low levels of Arc/Arg3.1 protein are required
for optimal homeostatic upregulation of AMPARs in-
duced by chronic inactivity. Indeed, since TTX treatment
also reduces endogenous Arc/Arg3.1 levels, we ob-
served greater relative downregulation of AMPARs
when Arc/Arg3.1 is overexpressed in the presence of TTX.
We next examined AMPAR expression in high-density
cortical neurons, a preparation optimized for biochemi-
cal assays of surface proteins and for electrophysiolog-
ical assays of synaptic events (Rumbaugh et al., 2003,
2006). In contrast to hippocampal cultures, Arc/Arg3.1
expression driven by a Sindbis viral vector had little
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477Figure 2. Arc/Arg3.1 Overexpression Blocks TTX-Induced Synaptic Scaling
(A) Representative images of Arc/Arg3.1 transgene expression in low-density hippocampal neurons, showing a reduction of surface GluR1 as
compared to neighboring untransfected cells, 16 hr posttransfection. Treatment with TTX-enhanced surface GluR1, which was blocked by ex-
pression of Arc/Arg3.1 transgene. (White boxes show magnified Arc/Arg3.1 transfected dendrites and yellow boxes highlight untransfected den-
drites. (Scale bars, 30 mm and 8 mm in magnified dendrites).
(B) Quantification of surface GluR1 experiments. Results from one experiment are shown and are representative of data collected from at least
two other experiments. Arc/Arg3.1 expression causes a significant decrease in the total intensity of surface GluR1 puncta (64%6 5% of untrans-
fected cells, n = 42 dendritic regions from 14 cells) compared with neighboring untransfected cells (n = 42/14). TTX treatment significantly en-
hanced GluR1 intensity (136%6 10%, n = 42/14). Arc/Arg3.1 expression blocked the TTX-induced increase in surface GluR1 (46%6 3%, n = 42/
14). (*p  0.001).
(C) Western blots of primary high-density cortical cultures show that Arc/Arg3.1 Sindbis virus expression has no affect on surface GluR1 or 2
with no treatment but dramatically reduced surface levels when treated with TTX, blocking the upregulation observed in cells transfected
with GFP virus.
(D) Traces selected from recordings of untransfected, GFP + WT-Arc/Arg3.1-, or GFP + D91–100Arc/Arg3.1-transfected neurons. Histograms
represent the average mEPSC amplitude of each population. No change in amplitude or frequency was observed. (Scale = 20 pA, 400 ms).
(E) Traces selected from whole-cell recordings of untransfected GFP + WT-Arc/Arg3.1 or GFP +D91–100Arc/Arg3.1-expressing neurons. In each
case, neurons were treated with 1 mM TTX for 48 hr. mEPSCs were only downregulated in WT-Arc/Arg3.1-expressing neurons. (*p < 0.05).
(F) Left: Cumulative probability distribution of mEPSC amplitudes from all events in either untransfected (U; n = 2597) or GFP + Arc/Arg3.1 (G+A;
n = 2450)-transfected neurons. Right: Cumulative probability distribution of mEPSC amplitudes from all events in either untransfected (U; n =
1540) or GFP + Arc/Arg3.1 (G+U; n = 1476)-transfected neurons. These neurons were treated with 1 mM TTX for 48 hr.
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478effect on AMPAR surface expression as detected by
surface biotinylation (Figure 2C). We asked whether
this difference might be due to high levels of neuronal
network activity and endogenous Arc/Arg3.1 expression
common to high-density cortical cultures. Consistent
with this hypothesis, treatment with TTX, which reduces
the endogenous level of Arc/Arg3.1, revealed a striking
effect of Arc/Arg3.1 transgene expression on surface
AMPARs. Arc/Arg3.1-expressing neurons treated with
TTX exhibited an w50% reduction of surface AMPARs
compared to control neurons expressing only GFP.
Similarly, electrophysiological recordings from these
neurons demonstrated that, in the absence of TTX,
Arc/Arg3.1 transgene expression had no effect on the
amplitude of AMPAR-mediated mEPSCs (Figure 2D).
By contrast, in the presence of TTX, Arc/Arg3.1 trans-
gene reduced the amplitude of AMPAR-mediated
mEPSCs (Figure 2E) and blocked the TTX-induced scal-
ing effect. Importantly, cumulative probability distribu-
tions of mEPSC amplitudes were uniformly reduced by
Arc/Arg3.1 transgene expression (Figure 2F). This sug-
gests that Arc/Arg3.1 scales AMPAR responses in
a manner similar to activity-dependent homeostatic
synaptic scaling. Strikingly, we found that a deletion
mutant of Arc/Arg3.1 (aaD91–100) that does not interact
with endophilin (Chowdhury et al., 2006) had no effect on
mEPSCs and did not block the TTX-induced increase in
mEPSCs (Figures 2D and 2E). Since this region is also re-
quired for downregulation of AMPARs (Chowdhury et al.,
2006), these data provide compelling evidence that
Arc/Arg3.1 regulates homeostatic scaling of AMPARs
though a molecular interaction with the endocytic
machinery.
Loss of Arc/Arg3.1 Results in Increased AMPAR
Function that Mimics the Homeostatic State Induced
by Chronic Inactivity
To assess the function of endogenous Arc/Arg3.1, we
performed various experiments on Arc/Arg3.1 KO
mice. These mice are viable and do not exhibit any gross
changes in neural architecture (Plath et al., 2006). We
isolated primary neurons from these mice and com-
pared them with neurons derived from wild-type (WT)
animals. To further explore the contribution of Arc/
Arg3.1 in homeostasis, we examined surface AMPAR
levels in Arc/Arg3.1 KO neurons using DIV 21–28 low-
density hippocampal neurons. If endogenous Arc/
Arg3.1 is involved in promoting the removal of AMPARs
from synapses, then neurons lacking Arc/Arg3.1 might
exhibit an increase in steady-state levels of these recep-
tors. In support of this hypothesis, we found that Arc/
Arg3.1 KO neurons exhibit a dramatic increase in
surface GluR1 when compared with WT neurons (Fig-
ure 3A). Puncta from Arc/Arg3.1 KO neurons exhibit in-
creased size, number, and intensity compared with WT
neurons (see Figure S1 in the Supplemental Data avail-
able with this article online), suggesting a global upregu-
lation of surface GluR1 levels. Importantly, cultured Arc/
Arg3.1 KO neurons form similar numbers of synapses
and have a normal compliment of synaptic proteins
when compared to WT neurons (Figures 3C and S2). In
contrast to GluR1 surface levels, surface GluR2 levels
were unchanged in Arc/Arg3.1 KO neurons (Figure 3B),
suggesting that the removal of endogenous Arc/Arg3.1from synapses changes the subunit composition of
AMPARs to favor GluR1-containing receptors.
The cell biological observations made in Arc/Arg3.1
KO neurons cannot definitively show that increases in
surface AMPARs lead to changes in synaptic strength.
To directly examine this issue, AMPAR-mediated
mEPSCs were recorded from WT and Arc/Arg3.1 KO
neurons. Arc/Arg3.1 KO neurons possessed larger
AMPAR-mediated mEPSC amplitudes relative to WT
neurons (Figure 3D). Notably, the increase of mEPSC
amplitudes was distributed over the entire range of re-
corded events, as shown by cumulative probability dis-
tributions (Figure 3D). This is similar to the homeostatic
synaptic scaling that occurs in WT neurons treated with
TTX. Thus, reduction of Arc/Arg3.1, by either genetic de-
letion or TTX, results in a similar state of enhanced sur-
face AMPAR expression and function.
Arc/Arg3.1 Regulates Homeostatic Synaptic Scaling
of AMPARs
To directly assess the effect of Arc/Arg3.1 in homeostatic
scaling of AMPARs, we treated both WT and Arc/Arg3.1
KO low-density hippocampal neurons with TTX or bicu-
culline for 48 hr and examined surface AMPAR levels.
WT mouse neurons exhibited a robust increase in surface
GluR1 after TTX treatment and significantly lower surface
levels after bicuculline treatment (Figure 4A). Strikingly,
Arc/Arg3.1 KO neurons exhibited no changes in surface
GluR1 levels after either treatment indicating a complete
absence of activity-dependent homeostatic scaling of
AMPARs in hippocampal neurons (Figure 4A). In electro-
physiological assays, TTX treatment of WT neurons re-
sulted in a significant increase in mEPSC amplitudes
and a multiplicative shift in the cumulativeprobability dis-
tribution, indicative of synaptic scaling of AMPARs
(Figure 4B). By contrast, Arc/Arg3.1 KO neurons treated
with TTX failed to exhibit an enhancement of mEPSC am-
plitudes (Figure 4C), possibly because KO neurons are
already homeostatically upregulated. In response to
bicuculline, both WT and Arc/Arg3.1 KO neurons ex-
hibited a modest downregulation of AMPAR (Figures
4B and 4C). This result contrasts with histochemical
assays in hippocampal neurons and suggests that mech-
anisms in addition to Arc/Arg3.1 may contribute to
AMPAR downregulation in highly active cortical neurons.
We next asked whether the absence of homeostatic
increases of AMPARs in Arc/Arg3.1 KO neurons follow-
ing TTX treatment might be due to saturation of mecha-
nisms that can deliver AMPARs to the cell surface. To
address this issue, we briefly stimulated WT and Arc/
Arg3.1 KO neurons with glycine, a treatment that results
in a rapid and persistent change in synaptic function
though the insertion of AMPARs. This process is be-
lieved to mimic LTP (Liao et al., 2001; Lu et al., 2001).
Glycine treatment produced an equivalent increase of
surface AMPAR in WT and Arc/Arg3.1 KO neurons (Fig-
ure 5). Thus, AMPAR insertion in response to transient
synaptic activation is intact in Arc/Arg3.1 KO neurons.
Discussion
The present studyprovides evidence that Arc/Arg3.1 me-
diates synaptic scaling of AMPARs over a broad range of
synaptic activity in mature neurons. Arc/Arg3.1 directly
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479Figure 3. Surface GluR1 and Synaptic Strength Are Increased in Arc/Arg3.1 KO Mice
(A) Representative pictures of surface GluR1 in WT and KO primary hippocampal neurons. Arc/Arg3.1 KO neurons (n = 60/20) have significantly
increased surface levels compared to Arc/Arg3.1 WT neurons (n = 54/18). Similar results are reported in Figure 8A of Chowdhury et al. (2006),
although the results reported reflect two different experiments. (* p < 0.001).
(B) Representative pictures of surface GluR2 in WT and KO primary hippocampal neurons. No significant difference in surface GluR2 levels was
observed (p = 0.2). (Scale bar, 30 mm).
(C) Western blots of synaptic proteins in WT and Arc/Arg3.1 KO neurons obtained from total and P2 fractionated brain lysates, showing no
dramatic changes in protein expression.
(D) Traces selected from recordings of either WT (n = 23) or Arc/Arg3.1 KO (n = 21) neurons. Histograms represent the average mEPSC
amplitude or frequency of each population. Arc/Arg3.1 KO neurons have significantly higher mEPSC amplitudes (*p < 0.01). (Scale = 30 pA,
100 ms). Cumulative probability distribution of mEPSC amplitudes from all events in either WT (n = 2454) or Arc/Arg3.1 KO (n = 2222) neurons
are shown.interacts with components of the endocytic pathway,
including dynamin and endophilin, and selectively in-
creases the rate of AMPAR endocytosis (Chowdhury
et al., 2006). These data suggest the following model: in
the absence of Arc/Arg3.1 or in conditions of persistent
low activity where Arc/Arg3.1 expression is dramatically
reduced, Arc/Arg3.1-dependent endocytosis is mini-
mized, causing a shift in the steady-state AMPAR
distribution toward membrane insertion. In conditionsof persistent high activity, high levels of Arc/Arg3.1 are
available to facilitate endocytosis of AMPARs, with con-
sequent downregulation of synaptic AMPARs. Thus, Arc/
Arg3.1 acts to titrate surface AMPARs, and this allows
optimal synaptic plasticity by maintaining distributed
synaptic weights. Periods of sustained Arc/Arg3.1 ex-
pression act to regulate synaptic scaling and thus coun-
teract saturation of synaptic strength inherent in Hebbian
positive-feedback loops.
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480Figure 4. Synaptic Scaling of AMPARs Is Abolished in Arc/Arg3.1 KO Neurons
(A) Representative images of surface GluR1 in WT and KO neurons treated for 2 days with TTX or bicuculline. WT neurons undergo significant
scaling, with an increase in surface levels with TTX and a decrease in surface levels with bicuculline treatment. In contrast, KO neurons do not
exhibit any changes in surface levels. (Scale bar, 30 mm). Quantification of surface levels show that WT neurons have a significant decrease in
total intensity (n = 30/11 for all) with TTX treatment and a significant increase in intensity with bicuculline treatment. In contrast, no significant
difference in surface GluR1 intensity was observed in KO neurons treated with TTX (p = 0.5) or bicuculline (p = 0.5). (*p < 0.001).
(B) Top: Representative mEPSC (averaged;w100 events) from a control (n = 9), TTX (1 mM; 48 hr; n = 9)-, or bicuculline (20 mM; 48 hr; n = 9)-treated
WT mouse neuron. Bottom: Histograms represent the average mEPSC amplitude or frequency of each population. mEPSC amplitudes are sig-
nificantly higher after TTX treatment (*p < 0.05). (Scale = 10 pA, 5 ms). Right: Cumulative probability distribution of mEPSC amplitudes from all
events in control, TTX-, and bicuculline-treated WT neurons.
(C) Top: Representative mEPSC (averaged;w100 events) from a control (n = 15), TTX (1 mM; 48 hr; n = 15)-, or bicuculline (20 mM; 48 hr; n = 10)-
treated Arc/Arg3.1 KO mouse neuron. Histograms represent the average mEPSC amplitude or frequency of each population. In contrast to WT
neurons, TTX treatment does not result in an increase in mEPSC amplitude. (Scale = 10 pA, 5 ms). Right: Cumulative probability distribution of
mEPSC amplitudes from all events in control, TTX-, and bicuculline-treated KO neurons. Virtually no scaling of amplitudes can be observed in
KO neurons.Molecular Mechanisms Underlying Homeostatic
Scaling of AMPA Receptors
Homeostatic synaptic scaling of AMPARs has been
elegantly described in physiological terms in both corti-cal and hippocampal neurons (O’Brien et al., 1998;
Thiagarajan et al., 2005; Turrigiano et al., 1998). Cortical
neurons consistently exhibit changes in mEPSC ampli-
tude without any changes in frequency, suggestingFigure 5. Arc/Arg3.1 KO Neurons Exhibit Normal Insertion of GluR1 Immediately after Chemical LTP
Representative pictures of surface GluR1 in cultures treated with Glycine. Although Arc/Arg3.1 KO neurons have higher basal surface GluR1,
pictures were obtained to equalize WT and KO basal levels so as to directly compare changes induced with glycine treatment. Quantitation
of surface GluR1 shows that both WT and KO neurons showed robust and significant increases in surface levels 10 min after glycine treatment
(*p  0.001).
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481a postsynaptic mechanism. In contrast, hippocampal
neurons have been reported to exhibit increases in
mEPSC amplitude and frequency (Thiagarajan et al.,
2002). Presynaptic changes such as enlargement of pre-
synaptic terminals and their vesicle pools have also
been observed in hippocampal neurons (Murthy et al.,
2001). Further complicating these results, a recent study
showed that the expression locus of homeostasis is
governed by how long the cultures are incubated in vitro
and not by cell type. In both cortical and hippocampal
neurons, 2 days of TTX treatment induced an increase
in mEPSC amplitude in cells that were less than 14
DIV, without affecting mEPSC frequency. However, in
cultures older than 18 DIV, the same treatment induced
a large increase in mEPSC frequency and a reduced ef-
fect on amplitude (Wierenga et al., 2006). The molecular
mechanisms underlying these changes are unclear. Our
results implicate Arc/Arg3.1 as one member of a molec-
ular pathway that permits AMPAR scaling, but these
data do not address other homeostatic mechanisms of
regulating neuronal output. We find differences in the
action of Arc/Arg3.1 in hippocampal versus cortical neu-
rons. Arc/Arg3.1 is more effective in downregulating
AMPARs in low-density hippocampal cultures than in
high-density cortical neurons. This is probably due to
lower basal Arc/Arg3.1 in low-density neurons, but we
cannot rule out region specific differences in cofunc-
tional molecules.
In hippocampal neurons, homeostatic increases in
surface AMPARs induced by prolonged inactivity have
been shown to be mainly due to increases in GluR2-
lacking receptors (Thiagarajan et al., 2005). In our stud-
ies of Arc/Arg3.1 KO neurons, Arc/Arg3.1 effects appear
to be preferential for GluR1, as KO neurons show no
overt changes in surface GluR2, suggesting an increase
in GluR2-lacking receptors at the plasma membrane.
Arc/Arg3.1 expression in pyramidal neurons of hippo-
campal slice cultures produces a selective downregula-
tion of AMPARs that requires Arc/Arg3.1’s ability to bind
endophilin and is blocked by agents that inhibit NMDA
receptor-dependent LTD, including the calcineurin in-
hibitor FK506 and peptides that mimic the C terminus
of GluR2 (Rial Verde et al., 2006 [this issue of Neuron]).
However, when Arc/Arg3.1 is expressed in WT neurons,
we see downregulation of both GluR1 and GluR2
(Figure 2C). These results confirm that Arc/Arg3.1 can
endocytose GluR2 in an acute manner. It is possible
that the apparent GluR1 selectivity in the Arc/Arg3.1
KO is a consequence of long-term depletion of the pro-
tein. This may promote a shift in the subunit composition
of AMPAR pools toward more GluR2-lacking AMPARs,
similar to what is seen with prolonged inactivity. Further
work is needed to clarify Arc/Arg3.1’s precise role in
determining AMPAR subunit specificity.
A recent report indicates that TNF-a, which is derived
from glia, is required for homeostatic upregulation of
AMPARs in neurons induced by chronic activity block-
ade, but not downregulation due to increased activity
(Stellwagen and Malenka, 2006). The molecular mecha-
nism of TNF-a regulation remains to be determined in
both homeostasis and synaptic maturation. In addition,
it is unclear if TNF-a plays a direct role in information
storage or is just a permissive factor needed for correct
neuronal network development.Arc/Arg3.1 Mediates Homeostasis and Hebbian
Synaptic Plasticity
AMPARs are highly dynamic and undergo rapid shut-
tling between the plasma membrane and internal recy-
cling pools (Luscher et al., 1999; Park et al., 2004).
Both LTD and LTP involve modulation of endocytosis
and exocytosis of AMPA receptors and numerous
AMPA-interacting molecules such as PICK1 and NSF
have been shown to be important for regulating AMPAR
trafficking and synaptic plasticity (Song and Huganir,
2002). Long-term maintenance of LTP and LTD requires
new protein synthesis (Huber et al., 2000; Nguyen and
Kandel, 1996; Otani and Abraham, 1989), and both
LTP- and LTD-inducing stimuli enhance the production
of an overlapping set of proteins through shared bio-
chemical pathways such as the MAPK cascade and
the mTOR pathway. It has been hypothesized that syn-
apses are ‘‘tagged’’ by plasticity-inducing stimuli and
capture proteins that subserve LTP and LTD (Frey and
Morris, 1997). The molecular nature of the tag or the pre-
cise proteins that are captured are unknown. Both LTP
and LTD are disrupted in Arc/Arg3.1 KO mice (Plath
et al., 2006), and Arc/Arg3.1-induced synaptic depres-
sion mimics LTD in slices (Rial Verde et al., 2006). This
evidence suggests that Arc/Arg3.1 may be a critical
component for bidirectional plasticity. The direction
may be governed by the nature of the tag or the con-
text/prior history of the neuron (i.e., Arc/Arg3.1 could
critically regulate the metaplasticity of the cell). Basal
synaptic transmission and mEPSCs are normal in slices
from Arc/Arg3.1 KO mice (Plath et al., 2006). However,
slices have much lower spontaneous network activity
than primary culture (see Plath et al. [2006]), and thus
Arc/Arg3.1-dependent homeostasis is more apparent
in our culture model. In addition, there are numerous ho-
meostatic mechanisms that control basal transmission,
including intrinsic excitability and modulation of ion
channel properties (Marder and Goaillard, 2006). Since
Arc/Arg3.1 is deleted from birth, other homeostatic pro-
cesses could compensate and keep basal transmission
normal. Further experiments that manipulate Arc/Arg3.1
for acute periods in vivo are needed to directly look at
whether Arc/Arg3.1 is required for the maintenance of
normal basal transmission in a large population of cells.
It is intriguing that Arc/Arg3.1 is induced in the geno-
mic response to both homeostatic synaptic plasticity
and protein synthesis-dependent Hebbian plasticity,
as it has been proposed that they share underlying mo-
lecular mechanisms (Yeung et al., 2004). In vivo evi-
dence for the importance of Arc/Arg3.1’s role in homeo-
static plasticity comes from recent work showing that
Arc/Arg3.1 KO mice have deficits in orientation tuning
in the visual cortex (Wang et al., 2006). Arc/Arg3.1 KO
mice exhibit activation of a larger neuronal ensemble
with reduced orientation specificity. As a consequence,
the orientation selectivity of neuronal spiking activities is
significantly reduced. Suppression of responses at non-
preferred orientations was critically dependent on Arc/
Arg3.1 protein, whereas responses at preferred orienta-
tions were not significantly affected, suggesting Arc/
Arg3.1 plays a more critical role in less-active neurons
and thus may increase the signal-to-noise of the system.
Exactly how homeostasis affects Hebbian plasticity
remains unclear. It is possible that Arc/Arg3.1’s effects
Neuron
482on LTP/LTD are secondary to poor homeostatic scaling
in neurons or that these two processes may be indepen-
dent of each other. Our manipulations of Arc/Arg3.1 are
cell wide, whereas in vivo regulation may only affect
specific neuronal circuits. Thus, our data do not rule
out a role of Arc/Arg3.1 in metaplasticity of specific
synapses.
Arc/Arg3.1 and Consolidation of Memory
Arc/Arg3.1 KO mice exhibit deficits in long-term consol-
idation of memory (Plath et al., 2006) that could be linked
to changes in AMPAR homeostasis. Arc/Arg3.1 is nor-
mally expressed at high levels in brain of awake, behav-
ing animals (Lyford et al., 1995). The time course of the
mRNA and protein expression is rapid and transient
and returns to baseline levels within 2 hr (Ramirez-
Amaya et al., 2005). However, Arc/Arg3.1 can be repeat-
edly induced in the same network with repetition of the
same behavioral paradigm (Guzowski et al., 2006) and
is reactivated during periods when animals are resting
or sleeping, as the hippocampus is ‘‘off line’’ (Ramirez-
Amaya et al., 2005). Thus, Arc/Arg3.1 protein can be per-
sistently upregulated in specific neurons as they engage
in network-specific learning and consolidation. Our
studies predict that homeostatic-scaling is an ongoing
process in these neurons and is essential for consolida-
tion.
In summary, our findings suggest that Arc/Arg3.1 con-
trols surface AMPAR levels in a homeostatic manner
and acts to keep surface levels and subunit composition
optimal for Hebbian plasticity. These processes are re-
quired for consolidation of information. Arc/Arg3.1
may also play a key role in cognitive disorders, as dis-
ruption of Arc/Arg3.1 expression has been observed in
Fragile X mental retardation (Zalfa et al., 2003) and
Alzheimer’s disease (Dickey et al., 2003; Palop et al.,
2005). Further understanding of Arc/Arg3.1’s function
and regulated expression should help elucidate the mo-
lecular mechanisms of memory storage by linking pro-
tein-synthesis-dependent synaptic plasticity, AMPAR
trafficking, and homeostatic synaptic scaling.
Experimental Procedures
Expression Constructs
All the expression constructs were made by PCR. Internal deletion
and point mutant were made either using QuikChange Site-Directed
Mutagenesis Kit (Stratagene) or by megaprimer method (Barik,
2002). The sequence of the primers used to generate each mutant
will be supplied upon request. PCR products were cloned into ex-
pression vectorpRK5 (Genentech). All constructs were verified by
sequencing.
Antibodies
All antibodies were previously described or were acquired commer-
cially: Bassoon (Stressgen), GluR1-N (pAb, JH1816 [Rumbaugh
et al., 2003]), GluR1-C (JH1710 [Ye et al., 2000]), GluR2-C (pAb,
JH1707 [Blackstone et al., 1992]) pAb, Arc/Arg3.1 (pAb [Lyford
et al., 1995]), Arc/Arg3.1 (mAb, Santa Cruz), b-actin (mAb, Sigma),
a-CaMKII (mAb, Boehringer Mannheim), PSD-95 (mAb, Affinity Bio-
reagents).
Recombinant Sindbis Virus and Infection
Arc/Arg3.1 ORF was first subcloned into pIRES2-EGFP and trans-
ferred into pSinRep5 (Invitrogen). At 14–21 DIV, cultured neurons
were infected with virus. Experiments were usually performed 12–
16 hr after infection.Preparation of Crude Synaptosomal Fraction from Brain
The subcellular fractionation procedure was performed according to
the technique of Huttner et al. (1983). All procedures were performed
at 4C. In brief, rat brains were homogenized in 10 volumes of buff-
ered sucrose (0.32 M sucrose, 4 mM HEPES/NaOH [pH 7.4], 1 mM
EDTA, 1 mM EGTA, and protease inhibitors cocktail) with a glass-
Teflon homogenizer. The homogenate was centrifuged at 800 3 g
for 15 min, and the supernatant was collected. The supernatant
was again centrifuged at 9000 3 g for 15 min and pellet was
collected as crude synaptosomal fraction, P2.
Coimmunoprecipitation and Immunoblotting
Six- to eight-week-old Arc/Arg3.1 WT and KO mice were sacrificed
by decapitation and forebrain regions dissected. Protein concentra-
tion of an aliquot of total homogenate was measured. The rest of the
homogenate was used for P2 fractionation as described above, and
protein concentration of an aliquot of P2 was measured. Equal
amount of total protein from WT and KO was loaded. For coimmuno-
precipitation, crude synaptosomal fraction (P2) was sonicated in
PBS with 1% Triton X-100, 1mM EDTA, 1 mM EGTA, and protease
inhibitors cocktail (Roche). The homogenate was centrifuged at
100,000 3 g for 20 min at 4C, and supernatants with equal amount
of protein were incubated with 2 mg of rabbit polyclonal antibodies
for GluR1 and GluR2. After 1.5 hr of mixing at 4C protein A agarose
slurry was added and incubated for another hour. The beads were
washed with PBS + 1%Triton X-100 three times and eluted with
SDS loading buffer. The samples were than analyzed by SDS-
PAGE and western blotting.
Biotinylation Assay
For surface biotinylation, infected or drug-treated cortical neurons
were cooled on ice, washed twice with ice-cold PBS containing
1 mM CaCl2 and 0.5 mM MgCl2, and then incubated with PBS con-
taining 1 mM CaCl2, 0.5 mM MgCl2, and 1 mg/ml Sulfo-NHS-SS-
Biotin (Pierce) for 30 min at 4C. Unreacted biotin was quenched
by washing cells three times with ice-cold 100 mM Glycine (pH 7.4).
Cultures were harvested in RIPA buffer. Homogenates were centri-
fuged at 132,000 rpm for 20 min at 4C. The resulting supernatant vol-
ume was measured and 15% of it separated as the total protein. The
remaining 85% of the homogenate was rotated overnight at 4C with
Streptavidin beads (Pierce). Precipitates were washed with RIPA
buffer and analyzed by immunoblotting with each antibody.
Cell Culture and Neuronal Transfection
Low-density hippocampal neurons were prepared as described pre-
viously (Banker and Cowan, 1977). High-density cortical cultures
from embryonic day 18 (E18) rat pups were prepared as reported pre-
viously (Rumbaugh et al., 2003). Mouse cultures were prepared in
a similar manner from E16.5–E17.5 mouse pups. Neuronal transfec-
tions were performed with Lipofectamine 2000 (Invitrogen) in DIV 12–
14 neurons and were analyzed 16–24 hr after initial incubation.
Immunocytochemistry, Microscopy, and Data Analysis
Cells were fixed in 4% paraformaldehyde, 4% sucrose containing
PBS solution for 20 min at 4C and were subsequently permeabilized
with 0.2% Triton X-100 in PBS for 10 min. Cells were then blocked for
1 hr in 10% normal donkey/goat serum (NGS). Primary antibodies
were diluted in 10% NGS and incubated with neurons for 1 hr at
room temperature or overnight at 4C. Alexa 488, Alexa 555, or Alexa
647-conjugated secondary antibodies (1:500; Molecular Probes) to
the appropriate species were diluted in 10% NDS and incubated
at room temperature for 1 hr. Coverslips were mounted on pre-
cleaned slides with PermaFluor and DABCO.
To label surface GluR1-containing AMPA receptors, 2.5 mg of
GluR1-N JH1816 pAb was added to neuronal growth media and in-
cubated at 10C for 20 min. The unbound excess antibody was
quickly washed with fresh warmed growth medium and then fixed
and mounted according to the methods described above.
Glycine stimulation was carried out as described before (Watt
et al., 2004). Neurons were incubated at 37C and 5% CO2 for
15 min in ACSF containing the following: NaCl, 126 mM; KCl,
5.5 mM; MgSO4, 0.4 mM; NaH2PO4, 1 mM; NaHCO3, 25 mM; CaCl2,
2 mM; dextrose, 14 mM; glycine, 0.2 mM; bicuculline, 0.01 mM.
Then, we replaced the medium in the culture dishes and returned
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483them to the tissue culture incubator until immunocytochemistry was
performed. Immunofluorescence was viewed and captured using
a Zeiss LSM 510 confocal laser scanning microscope. Quantification
of surface GluR1 puncta were carried out essentially as described
(Rumbaugh et al., 2003), using Metamorph imaging software (Univer-
sal Imaging). Images were acquired and saved as multichannel TIFF
files with a dynamic range of 65,536 gray levels (16-bit binary; Multi-
Track acquisition for confocal). To measure punctate structures,
neurons were thresholded by gray value at a level close to 50% of
the dynamic range. Background noise from these images was negli-
gible. After a dendrite segment was selected, all puncta were treated
as individual objects and the characteristics of each, such as pixel
area, average fluorescence intensity, and total fluorescence inten-
sity, were logged to a spreadsheet. In addition, each dendrite length
was logged in order to calculate puncta density and total intensity per
dendritic length (all values shown are per 10 mm of dendrite). Trans-
fected cells were compared with neighboring untransfected cells in
individual coverslips. The average single pixel intensity from each
region was calculated and averages from all regions were derived.
Significance was determined by a paired Student’s t test.
Electrophysiology and mEPSC Analysis
Whole-cell patch-clamp recordings were performed from forebrain
cultures at the DIV indicated. To isolate AMPAR-mediated mEPSCs,
neurons were continuously perfused with artificial cerebral-spinal
fluid (aCSF) at a flow rate of 1 ml/min. The composition of aCSF
was as follows: 150 mM NaCl, 3.1 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, 10 mM HEPES, 0.1 mM DL-APV, 0.005 mM strychnine,
0.1 mM picrotoxin, and 0.001 mM tetrodotoxin. The osmolarity of
aCSF was adjusted to 305–310 and pH was 7.3–7.4. Intracellular
saline consisted of the following: 135 mM Cs-MeSO4, 10 mM CsCl,
10 mM HEPES, 5 mM EGTA, 2 mM MgCl2, 4 mM Na-ATP, and
0.1 mM Na-GTP. This saline was adjusted to 290–295 mOsm, and
pH was 7.2.
Transfected neurons were selected based on fluorescent (eGFP)
signal. Once the whole-cell recording configuration was achieved,
neurons were voltage clamped and passive properties were moni-
tored throughout. In the event of a change in series resistance (Rs)
or input resistance (Ri) >15% during the course of a recording, the
data were excluded from the set. mEPSCs were acquired through
a MultiClamp 700A amplifier (Axon Instruments), filtered at 2 kHz,
and digitized at 5 kHz. Sweeps of 20 s with zero latency (essentially
‘‘gap free’’) were acquired until a sufficient number of events were
recorded (a minimum of 5 and no longer than 30 min). Data were re-
corded continuously only after a period of 2 minutes, during which
the cell was allowed to stabilize. mEPSCs were detected manually
with MiniAnalysis software (Synaptosoft Inc) by setting the ampli-
tude threshold to O RMS 3 3 (usually 4 pA). Once a minimum of
100 events had been collected from a neuron, the amplitude, fre-
quency, rise time (time to peak), decay time (10%–90%), and passive
properties were measured. In all electrophysiological experiments,
a similar amount of data was acquired from both transfected and
untransfected neurons on the same day. We have found that record-
ing transfected neurons followed by recording an untransfected
neuron in the immediate vicinity yields remarkably consistent re-
sults. This is likely a result of reducing errors that arise from slight
changes in neuronal density between preps or changes in the den-
sity of neurons from different areas of a coverslip. These parameters
were crucial for obtaining reliable, low-variability data between
experimental populations. Data from each group were then aver-
aged, and statistical significance was determined by Student’s
t test (unless noted otherwise). All electrophysiological experiments
were performed from at least two individual platings of neurons from
three different transfections.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/3/475/DC1/.
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